I took up my allocation in the recent offering at 17c only to be down 50c.
I agree that the outlook looks very good. Because of the history of poor outcomes in this sector - anything that looks promising will be fast tracked.
- Forums
- ASX - By Stock
- CHM
- Ann: First phase 1B trial of NK cells with IL-2 & Vactosertib
Ann: First phase 1B trial of NK cells with IL-2 & Vactosertib, page-18
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CHM (ASX) Chart |
Day chart unavailable